Thiol-induced nitric oxide release from 3-halogeno-3,4-dihydrodiazete 1,2-dioxides

Journal of Medicinal Chemistry

Volumn 41, Issue 7, 1998, Pages 1027-1033

  Kirilyuk, Igor A ^a   Utepbergenov, Darkhan I ^c   Mazhukin, Dmitrii G ^a   Fechner, Klaus ^c   Mertsch, Katharina ^c   Khramtsov, Valery V ^b   Blasig, Ingolf E ^c   Haseloff, Reiner F ^c  

^a N N VOROZHTSOV NOVOSIBIRSK INSTITUTE OF ORGANIC CHEMISTRY   (Russian Federation)

^b INSTITUTE OF CHEMICAL KINETICS AND COMBUSTION   (Russian Federation)

^c LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2A,3,4,5,6,6A HEXAHYDRO 2A CHLORO 6A METHYLBENZODIAZETE 1,2 DIOXIDE; 3 BROMO 3,4 DIHYDRO 3,4,4 TRIMETHYLDIAZETE 1,2 DIOXIDE; 3,4 DIHYDRO 3 CHLORO 3,4,4 TRIMETHYLDIAZETE 1,2 DIOXIDE; ACETYLCYSTEINE DERIVATIVE; AZETIDINE DERIVATIVE; CYSTEINE; GLUTATHIONE; NITRIC OXIDE; THIOL DERIVATIVE; UNCLASSIFIED DRUG; VASODILATOR AGENT;

ANIMAL CELL; ANIMAL TISSUE; AORTA; ARTICLE; CATTLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG SYNTHESIS; ELECTRON SPIN RESONANCE; MESENTERIC ARTERY; NONHUMAN; REACTION ANALYSIS; THROMBOCYTE AGGREGATION INHIBITION; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; CYCLIC N-OXIDES; MESENTERIC ARTERIES; NITRIC OXIDE; RATS; SULFHYDRYL COMPOUNDS; VASODILATION; VASODILATOR AGENTS;

EID: 0032568421     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm960737s     Document Type: Article

References (30)

1. (a) Ullman, E. F.; Singh, P. 3,3,4,4-Tetramethyl-1,2-diazetine 1,2-dioxide, a useful low-energy triplet quencher. J. Am. Chem. Soc. 1972, 94, 5077-5078.
2. (b) Volodarsky, L. B.; Tikhonova, L. A. Formation of furoxanes and 1,2-diazetine-1,2-dioxides upon α-hydroxylaminooximes oxidation. Khim. Geterotsykl. Soedin. 1975, 6, 748-752 (in Russian).
3. (a) Severina, I. S.; Ryaposova, I. K.; Volodarsky, L. B.; Mazhukin, D. G.; Tikhonov, A. Ya.; Schwartz, G. Ya.; Granik, V. G.; Grigoryev, D. A.; Grygoryev, N. B. Derivatives of 1,2-diazetidine-1,2-di-N-oxides - a new class of soluble guanylate cyclase activators with vasodilatory properties. Biochem. Mol. Biol. Int. 1993, 30, 357-366.
4. (b) Utepbergenov, D. I.; Khramtsov, V. V.; Vlassenko, L. P.; Markel, A. L.; Mazhukin, D. G.; Tikhonov, A. Ya.; Volodarsky, L. B. Kinetics of nitric oxide liberation by 3,4-dihydro-1,2-diazete 1,2-dloxides and their vasodilatory properties in vitro and in vivo. Biochem. Biophys. Res. Commun. 1995, 214, 1023-1032.
5. Severina, I. S.; Belushkina, N. N.; Grigoryev, N. B. Inhibition of ADP-induced human platelet aggregation by a new class of soluble guanylate cyclase activators capable of nitric oxide generation. Biochem. Mol. Biol. Int. 1994, 33, 957-967.
6. Ryaposova, I. K.; Grigoryev, N. B.; Severina, I. S. A new class of soluble guanylate cyclase activators, generating nitric oxide. Biokhimiya (Moscow) 1994, 59, 537-542 (in Russian),
7. (e) Belushkina, N. N.; Grigoryev, N. B.; Severina, I. S. Inhibition of human platelet aggregation by a new class of soluble guanylate cyclase inhibitor, generating nitric oxide. Biokhimiya (Moscow) 1994, 59, 1689-1697 (in Russian).
8. (a) Feelisch, M.; Schönafinger, K.; Noack, E. Thiol-mediated generation of nitric oxide accounts for the vasodilator action of furoxans. Biochem. Pharmacol. 1992, 44, 1149-1155.
9. (b) Fukuyama, S.; Hirasawa, Y.; Cox, D.; Koda, S.; Kita, Y. Acceleration of nitric oxide (NO) release from FK409, a spontaneous NO releaser, in the presence of sulfhydryl-bearing compounds. Pharm. Res. 1995, 12, 1948-1952.
10. Feelisch, M.; te Poel, M.; Zamora, R.; Deussen, A.; Moncada, S. Understanding the controversy over the identity of EDRF. Nature 1994, 368, 62-65.
11. Tikhonova, L. A.; Volodarsky, L. B. Properties of 3-bromo-1,2-diazetine-1,2-dioxides. Izv. Sib. Otd. Akad. Nauk SSSR, Ser. Khim. Nauk 1977, 1, 103-106 (in Russian).
12. (a) Gorren, A. C. F.; Schrammel, A.; Schmidt, K.; Mayer, B. Decomposition of S-nitrosoglutathione in the presence of copper ions and glutathione. Arch. Biochem. Biophys. 1996, 330, 219-228.
13. + as the effective reagent in nitric oxide formation from S-nitrosothiols (RSNO). J. Chem. Soc., Perkin Trans. 2 1996, 481-487.
14. Kharitonov, V. G.; Sundquist, A. R.; Sharma, V. S. Kinetics of nitrosation of thiols by nitric oxide in the presence of oxygen. J. Biol. Chem. 1995, 270, 28158-28164.
15. Winterbourn, C. C.; Metodiewa, D. Reaction of Superoxide with glutathione and other thiols. Methods Enzymol. 1995, 251, 81-86.
16. Khlestkin, V. K.; Mazhukin, D. G.; Tikhonov, A. Ya.; Bagryanskaya, I. Yu.; Gatilov, Yu. V.; Utepbergenov, D. I.; Khramtsov, V. V.; Volodarsky, L. B. Unexpected transformation of 1,2-bis(N-methoxy-N-nitrosoamino)cycloalkanes: First synthesis of 4,5-dihydro-1,2,3-triazole 2-oxides. Tetrahedron Lett. 1996, 37, 5997-6000.
17. Gilchrist, T. L. Nitroso-alkynes and nitroso-alkenes. Chem. Soc. Rev. 1983, 12, 53-73.
18. Maragos, C. M.; Morley, D.; Wink, D. A.; Dunams, T. M.; Saavedra, J. E.; Hoffman, A.; Bove, A. A.; Isaak, L.; Hrabie, J. A.; Keefer, L. K. Complexes of ·NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects. J. Med. Chem. 1991, 34, 3242-3247.
19. Meister, A.; Anderson, M. E. Glutathione. Annu. Rev. Biochem. 1983, 52, 711-760.
20. Yu, B. P. Cellular defenses against damage from reactive oxygen species. Physiol. Rev. 1994, 74, 139-162.
21. Greene, F. D.; Gilbert, K. E. Cyclic azo dioxides. Preparation, properties and consideration of azodioxide-nitrosoalkane equilibria. J. Org. Chem. 1975, 40, 1409-1415.
22. (a) Volodarsky, L. B.; Putsykin, Yu. G. Chemistry of α-hydroxylaminooximes. XI. Synthesis of alicyclic α-hydroxylaminooximes. Zh. Org. Khim. 1967, 3, 1686-1694 (in Russian),
23. (b) Putsykin, Yu. G.; Volodarsky, L. B. Synthesis of aliphatic α-hydroxylaminooximes from olefine nitrosochlorides. Izv. Sib. Otd. Akad. Nauk SSSR, Ser. Khim. Nauk. 1968, 4, 101-105 (in Russian).
24. Boswell, G. A. Reaction of nitrosyl fluoride and selected steroid enes. A new synthesis of δ5-keto steroids. J. Org. Chem. 1968, 33, 3699-3713.
25. Murphy, M. E.; Noack, E. Nitric oxide assay using hemoglobin method. Methods Enzymol. 1994, 233, 240-246.
26. Halle, W.; Siems, W. E.; Jentsch, K. D.; Teuscher, E.; Göres, E. Die in vitro kultivierte Aorten-Endothelzelle in der Wirkstoff-forschung - Zellphysiologische Charakterisierung und Einsatz-möglichkeiten der Zellinie BKEz-7. Pharmazie 1984, 39, 77-81.
27. Haseloff, R. F.; Zöllner, S.; Kirilyuk, I. A.; Grigor'ev, I. A.; Reszka, R.; Bernhardt, R.; Mertsch, K.; Roloff, B.; Blasig, I. E. Super- oxide-mediated reduction of the nitroxide group can prevent detection of nitric oxide by nitronyl nitroxides. Free Radical Res. 1997, 26, 7-17.
28. Mertsch, K.; Grune, T.; Siems, W. G.; Landhoff, A.; Saupe, N.; Blasig, I. E. Hypoxia and reoxygenation of brain endothelial cells in vitro: A comparison of biochemical and morphological response. Cell. Mol. Biol. 1995, 41, 243-253.
29. (a) Rohde, E.; Furkert, J.; Fechner, K.; Beyermann, M.; Mulvany, M. J.; Richter, R. M.; Denef, K.; Bienert, M.; Berger, H. Corticotropin-releasing hormone (CRH) receptors in the mesen- teric small arteries of rats resemble the (2)-subtype. Biochem. Pharmacol. 1996, 52, 829-833.
30. (b) Mulvany, M. J.; Halpern, W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ. Res. 1977, 41, 19-26.